Gastric Indolent cell carcinoma is one of the highly malignant tumors, characterized by strong invasive force and high malignancy, with a rapid progression of disease course, the natural course of which is only 3-6 months, and its cancer cells are prone to metastasis. It occurs mostly in young and middle-aged people, especially young women. Clinical experts believe that the occurrence of this disease may be related to the high estrogen metabolism of young women. Some patients show indigestion, such as upper abdominal discomfort, nausea and vomiting, abdominal pain and distension, acid reflux and belching, early satiety after meals, loss of appetite, hyperactive bowel sounds, abnormal stools, etc., which are easily missed. In the progressive stage, there may be abdominal pack fast, wasting, ascites, etc. Gastric Indolent cell carcinoma has diffuse infiltrative growth and easily infiltrates the whole stomach, and it is often accompanied by obvious fibrosis, which makes the whole stomach wall sclerosis and leather-like changes, once such changes occur, it enters the middle and late stage of gastric cancer. The factors that determine the prognosis of gastric cancer are related to the cell type, but also to the depth of cancer foci and the degree of lymph node metastasis. If early detection, early diagnosis and early treatment can be achieved, gastric Indolent cell carcinoma, like other types of gastric cancer, can still recover very well.